Feb 03, 2026
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $10.62 to $159.30.
The split itself did not change the total investment value.
Atossa Therapeutics, Inc. (BMV:ATOS) operates in the Pharmaceuticals: major industry.
Atossa Therapeutics, Inc. company overviewAtossa Therapeutics, Inc.'s most recent stock split was on February 3, 2026. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
Atossa Therapeutics, Inc. (BMV:ATOS) has split its stock 3 times: a 1-for-15 reverse split on August 26, 2016, a 1-for-12 reverse split on April 20, 2018, and a 1-for-15 reverse split on February 3, 2026.
Atossa Therapeutics, Inc. has split its stock 3 times. This history records 3 reverse splits between August 26, 2016 and February 3, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Atossa Therapeutics, Inc.'s 1-for-15 reverse split on February 3, 2026, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Atossa Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on February 3, 2026, less than a year ago. Companies announce splits in advance, and any new BMV:ATOS split will appear on this page.